Bank of New York Mellon’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.8M Sell
802,245
-181,597
-18% -$12.4M 0.01% 932
2026
Q1
$63.6M Buy
983,842
+22,713
+2% +$1.6M 0.01% 856
2025
Q4
$64.7M Sell
961,129
-91,911
-9% -$6.18M 0.01% 857
2025
Q3
$77.2M Buy
1,053,040
+150,056
+17% +$9.97M 0.01% 766
2025
Q2
$47M Sell
902,984
-79,016
-8% -$4.5M 0.01% 1039
2025
Q1
$62.7M Buy
982,000
+1,130
+0.1% +$65.6K 0.01% 826
2024
Q4
$46.9M Sell
980,870
-8,188
-0.8% -$420K 0.01% 1066
2024
Q3
$56.6M Sell
989,058
-191,622
-16% -$11M 0.01% 952
2024
Q2
$61.8M Sell
1,180,680
-33,505
-3% -$1.47M 0.01% 898
2024
Q1
$49.4M Sell
1,214,185
-79,291
-6% -$2.97M 0.01% 1044
2023
Q4
$47.8M Sell
1,293,476
-8,298
-0.6% -$313K 0.01% 1071
2023
Q3
$49.7M Sell
1,301,774
-28,860
-2% -$1.18M 0.01% 983
2023
Q2
$48M Sell
1,330,634
-59,037
-4% -$2.01M 0.01% 1038
2023
Q1
$53.1M Sell
1,389,671
-48,699
-3% -$2.28M 0.01% 978
2022
Q4
$81.8M Sell
1,438,370
-82,920
-5% -$4.25M 0.02% 700
2022
Q3
$60.2M Sell
1,521,290
-18,986
-1% -$839K 0.01% 839
2022
Q2
$67.8M Buy
1,540,276
+11,963
+0.8% +$517K 0.02% 801
2022
Q1
$61M Sell
1,528,313
-11,953
-0.8% -$426K 0.01% 973
2021
Q4
$61.9M Sell
1,540,266
-30,259
-2% -$1.13M 0.01% 1011
2021
Q3
$63.9M Buy
1,570,525
+92,038
+6% +$3.85M 0.01% 977
2021
Q2
$67.1M Buy
1,478,487
+34,490
+2% +$1.53M 0.01% 949
2021
Q1
$60.2M Sell
1,443,997
-28,115
-2% -$1.28M 0.01% 985
2020
Q4
$62.9M Buy
1,472,112
+753,065
+105% +$27.1M 0.01% 916
2020
Q3
$18.9M Buy
719,047
+22,839
+3% +$636K ﹤0.01% 1516
2020
Q2
$18.7M Buy
696,208
+73,316
+12% +$1.65M 0.01% 1488
2020
Q1
$11.2M Sell
622,892
-21,809
-3% -$414K ﹤0.01% 1634
2019
Q4
$11.4M Buy
644,701
+1,234
+0.2% +$21.4K ﹤0.01% 1895
2019
Q3
$9.98M Sell
643,467
-17,437
-3% -$287K ﹤0.01% 1936
2019
Q2
$11.4M Buy
660,904
+18,737
+3% +$302K ﹤0.01% 1892
2019
Q1
$10.3M Sell
642,167
-19,716
-3% -$319K ﹤0.01% 1955
2018
Q4
$9.68M Sell
661,883
-1,032,894
-61% -$16.5M ﹤0.01% 1921
2018
Q3
$30.8M Sell
1,694,777
-11,541
-0.7% -$202K 0.01% 1354
2018
Q2
$28.8M Sell
1,706,318
-8,642
-0.5% -$163K 0.01% 1371
2018
Q1
$33.6M Sell
1,714,960
-142,154
-8% -$2.75M 0.01% 1233
2017
Q4
$37.6M Sell
1,857,114
-242,050
-12% -$4.45M 0.01% 1167
2017
Q3
$36.5M Buy
2,099,164
+237,593
+13% +$3.22M 0.01% 1181
2017
Q2
$23.9M Buy
1,861,571
+55,081
+3% +$736K 0.01% 1442
2017
Q1
$23.4M Buy
1,806,490
+387,486
+27% +$4.9M 0.01% 1459
2016
Q4
$14M Sell
1,419,004
-303,500
-18% -$3.32M ﹤0.01% 1770
2016
Q3
$20.8M Sell
1,722,504
-557,197
-24% -$5.69M 0.01% 1445
2016
Q2
$19.7M Buy
2,279,701
+1,783,067
+359% +$17.6M 0.01% 1410
2016
Q1
$4.7M Sell
496,634
-1,292,312
-72% -$12.2M ﹤0.01% 2211
2015
Q4
$31M Buy
1,788,946
+1,282,775
+253% +$20.4M 0.01% 1098
2015
Q3
$6.8M Sell
506,171
-142,281
-22% -$2.86M ﹤0.01% 2061
2015
Q2
$14.6M Buy
648,452
+26,242
+4% +$461K ﹤0.01% 1715
2015
Q1
$8.88M Buy
622,210
+75,772
+14% +$1.09M ﹤0.01% 2006
2014
Q4
$5.27M Buy
546,438
+2,666
+0.5% +$23.7K ﹤0.01% 2290
2014
Q3
$4.95M Buy
543,772
+44,747
+9% +$426K ﹤0.01% 2321
2014
Q2
$4.93M Buy
499,025
+23,246
+5% +$197K ﹤0.01% 2331
2014
Q1
$6.04M Buy
475,779
+25,169
+6% +$374K ﹤0.01% 2211
2013
Q4
$6.75M Buy
450,610
+2,856
+0.6% +$36.7K ﹤0.01% 2114
2013
Q3
$4.94M Buy
447,754
+5,772
+1% +$48.1K ﹤0.01% 2258
2013
Q2
$3.51M Buy
+441,982
New +$2.81M ﹤0.01% 2401

Other funds holding HALO

Bank of New York Mellon's HALO Position: Q2 2026 in Review

Bank of New York Mellon reduced its Halozyme (HALO) stake by 18% in Q2 2026, selling an estimated $12.4M and leaving 802,245 shares worth $62.8M. The position accounts for 0.01% of the portfolio, ranked #932.

Bank of New York Mellon first reported a position in HALO in Q2 2013 and has held it in 53 quarters since. The position peaked at $81.8M in Q4 2022. 398 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Bank of New York Mellon held 802,245 shares of Halozyme worth $62.8M as of Q2 2026.
  • Bank of New York Mellon sold 181,597 Halozyme shares in Q2 2026, an estimated $12.4M.
  • Halozyme made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #932 holding.
  • Bank of New York Mellon first reported a position in Halozyme in Q2 2013 and has held it in 53 quarters since.
  • Bank of New York Mellon's Halozyme position peaked at $81.8M in Q4 2022.
  • 398 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.